News Medical on MSN9h
COPD patients' perspectives should guide development of new therapies
The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...
Patient perspectives central for developing new therapies for COPD
The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...
Medscape15h
Key Topics in 2025 GOLD Report Include CVD Risk, Spirometry
Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...
News Medical on MSN1d
Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patients
A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...
COPD Care: Thousands of Kiwis with common lung disease could benefit from new Australia care - specialist
Leading New Zealand health expert Lutz Beckert wants a new Australian Government standard of care for chronic obstructive ...
pulmonologyadvisor12h
In COPD, Luminal Airway Narrowing Linked to Respiratory Illness/Mortality
In COPD, respiratory morbidity and mortality are associated with airway luminal narrowing, a change that can be measured.
emjreviews.com14h
Lung Cancer Screening Benefits Limited for Smokers with Severe Airflow Limitation
A RECENT study examining the impact of airflow limitation (AL) on lung cancer (LC) screening outcomes suggests that the ...
Medindia13d
AI Urine Test can Predict Lung Disease Flare-Ups a Week Ahead
Artificial neural network risk prediction of chronic obstructive pulmonary disease (COPD) exacerbations using urine ...
Future Market Insights1d
Global Lung Disease Therapeutics Market Set to Reach USD 152,369.26 Million by 2033, Driven by Rising Prevalence and Advancements in Treatment | FMI
Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...